Anaphylaxis in the allergist's office: Preparing your office and staff for medical emergencies

Allergy and Asthma Proceedings

Volumn 34, Issue 2, 2013, Pages 120-131

  Wallace, Dana V ^a  

^a NOVA SOUTHEASTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; CORTICOSTEROID; DIPHENHYDRAMINE; DOPAMINE; GLUCAGON; LEVALBUTEROL; OXYGEN; RANITIDINE; SALBUTAMOL;

ANAPHYLAXIS; CONFERENCE PAPER; CRASH CART; DEFIBRILLATOR; FACE MASK; GLOVE; HUMAN; IMMUNOTHERAPY; NEEDLE; NURSING CARE; OXYGEN THERAPY; PATIENT EDUCATION; PRACTICE GUIDELINE; RESUSCITATION; STAFF TRAINING; SYRINGE; TOURNIQUET; TREATMENT PLANNING;

ALLERGY AND IMMUNOLOGY; ANAPHYLAXIS; CLINICAL PROTOCOLS; DESENSITIZATION, IMMUNOLOGIC; EMERGENCIES; HUMANS; INJECTIONS, SUBCUTANEOUS; MEDICAL STAFF; PHYSICIANS' OFFICES;

EID: 84876005100     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2013.34.3659     Document Type: Conference Paper

References (59)

1. Stewart GE II, and Lockey RF. Systemic reactions from allergen immunotherapy. J Allergy Clin Immunol 90:567-578, 1992.
2. Greenberg MA, Kaufman CR, Gonzalez GE, et al. Late and immediate systemic-allergic reactions to inhalant allergen immunotherapy. J Allergy Clin Immunol 77:865-870, 1986. (Pubitemid 16088496)
3. Roy SR, Sigmon JR, Olivier J, et al. Increased frequency of large local reactions among systemic reactors during subcutaneous allergen immunotherapy. Ann Allergy Asthma Immunol 99:82-86, 2007. (Pubitemid 47075956)
4. Harvey SM, Laurie S, Hilton K, and Khan DA. Safety of rush immunotherapy to multiple aeroallergens in an adult population. Ann Allergy Asthma Immunol 92:414-419, 2004. (Pubitemid 39077582)
5. Phillips JF, Lockey RF, Fox RW, et al. Systemic reactions to subcutaneous allergen immunotherapy and the response to epinephrine. Allergy Asthma Proc 32:288-294, 2011.
6. Mellerup MT, Hahn GW, Poulsen LK, and Malling H. Safety of allergen-specific immunotherapy. Relation between dosage regimen, allergen extract, disease and systemic side-effects during induction treatment. Clin Exp Allergy 30:1423-1429, 2000.
7. Lockey RF, Benedict LM, Turkeltaub PC, and Bukantz SC. Fatalities from immunotherapy and skin testing. J Allergy Clin Immunol 79:660-77, 1987.
8. Reid MJ, Lockey RF, Turkeltaub PC, and Platts-Mills TA. Survey of fatalities from skin testing and immunotherapy 1985-1989. J Allergy Clin Immunol 92:6-15, 1993. (Pubitemid 23234076)
9. Lockey RF, Nicoara-Kasti GL, Theodoropoulos DS, and Bukantz SC. Systemic reactions and fatalities associated with allergen immunotherapy. Ann Allergy Asthma Immunol 87(suppl 1):47-55, 2001. (Pubitemid 32661330)
10. Amin HS, Liss GM, and Bernstein DI. Evaluation of near-fatal reactions to allergen immunotherapy injections. J Allergy Clin Immunol 117:169-175, 2006. (Pubitemid 43017156)
11. Cohen JS. Gene-mimetic substances: Drugs designed to intervene in gene expression. Adv Pharmacol 25:319-339, 1994.
12. Feldman SE, and Roblin DW. Medical accidents in hospital care: applications of failure analysis to hospital quality appraisal. J Comm J Qual Improv 23:567-580, 1997.
13. Weeks WB, and Bagian JP. Developing a culture of safety in the Veterans Health Administration. ECP 3:270-276, 2000.
14. Cox L, Nelson H, Lockey R, et al. Allergen immunotherapy: A practice parameter third update. J Allergy Clin Immunol 127(suppl):S1-S55, 2011.
15. Immunotherapy Forms. 2010. Available online at www.acaai. org/members/PracticeResources/Documents/Allergen Immunotherapy-A Practice Parameter Third Update; accessed September 1, 2012.
16. Ragusa VF, and Massolo A. Non-fatal systemic reactions to subcutaneous immunotherapy: A 20-year experience comparison of two 10-year periods. Allerg Immunol (Paris) 36:52-55, 2004. (Pubitemid 38316066)
17. Moreno C, Cuesta-Herranz J, Fernandez-Tavora L, and Alvarez-Cuesta E. Immunotherapy safety: A prospective multi-centric monitoring study of biologically standardized therapeutic vaccines for allergic diseases. Clin Exp Allergy 34:527-531, 2004. (Pubitemid 38534882)
18. Matloff SM, Bailit IW, Parks P, et al. Systemic reactions to immunotherapy. Allergy Proc 14:347-350, 1993. (Pubitemid 23321747)
19. Gastaminza G, Algorta J, Audicana M, et al. Systemic reactions to immunotherapy: Influence of composition and manufacturer. Clin Exp Allergy 33:470-474, 2003. (Pubitemid 36520910)
20. Rank MA, Oslie CL, Krogman JL, et al. Allergen immunotherapy safety: Characterizing systemic reactions and identifying risk factors. Allergy Asthma Proc 29:400-405, 2008.
21. Lin MS, Tanner E, Lynn J, and Friday GA Jr. Nonfatal systemic allergic reactions induced by skin testing and immunotherapy. Ann Allergy 71:557-562, 1993. (Pubitemid 24005750)
22. Winther L, Arnved J, Malling HJ, et al. Side-effects of allergenspecific immunotherapy: A prospective multi-centre study. Clin Exp Allergy 36:254-260, 2006. (Pubitemid 43344706)
23. Alsamarai AM, Alobaidi AHA, Alwan AM, et al. Systemic adverse reaction to specific immunotherapy. J Allergy Ther 2:111, 2011.
24. DaVeiga SP, Liu X, Caruso K, et al. Systemic reactions associated with subcutaneous allergen immunotherapy: Timing and risk assessment. Ann Allergy Asthma Immunol 106:533-537 e2, 2011.
25. Epstein TG, Liss GM, Murphy-Berendts K, and Bernstein DI. Immediate and delayed-onset systemic reactions after subcutaneous immunotherapy injections: ACAAI/AAAAI surveillance study of subcutaneous immunotherapy: Year 2. Ann Allergy Asthma Immunol 107:426-431 e1, 2011.
26. Tinkelman DG, Cole WQ III, and Tunno J. Immunotherapy: A one-year prospective study to evaluate risk factors of systemic reactions. J Allergy Clin Immunol 95:8-14, 1995.
27. Malling HJ, and Weeke B. Position paper: Immunotherapy. The European Academy of Allergology and Clinical Immunology (EAACI). Allergy 48(suppl):7-35, 1993.
28. Canonica GW, Baena-Cagnani CE, Bousquet J, et al. Recommendations for standardization of clinical trials with allergen specific immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce. Allergy 62:317-324, 2007.
29. Lieberman P, Nicklas RA, Oppenheimer J, et al. The diagnosis and management of anaphylaxis practice parameter: 2010 Update. J Allergy Clin Immunol 126:477-480, e1-e42, 2010.
30. Bridges N, and Jarquin-Valdivia AA. Use of the Trendelenburg position as the resuscitation position: To T or not to T? Am J Crit Care 14:364-368, 2005. (Pubitemid 41330049)
31. Jimenez E. Modulating the response to injury (initial management for hypotension. In Critical Care, 3rd ed. Kirby RR, Taylor RW, Ciretta JM (Eds). Philadelphia: Lippincott Williams & Wulkins, p. 374-375, 1997.
32. Use of the Trendelenburg position to improve hemodynamics during hypovolemic shock. Available online at http://www. bestbets.org/bets/bet.php?id- 1710; accessed September 3, 2010.
33. Pumphrey RS. Fatal posture in anaphylactic shock. J Allergy Clin Immunol 112:451-452, 2003.
34. Nowak-Wegrzyn A. Personal communication. New York University, Mount Sinai Hospital, New York, NY; August 16, 2011.
35. Simons FE, Ardusso LR, Bilo MB, et al. World Allergy Organization anaphylaxis guidelines: Summary. J Allergy Clin Immunol 127:587-593, e1-e22, 2011.
36. Korenblat P, Lundie MJ, Dankner RE, and Day JH. A retrospective study of epinephrine administration for anaphylaxis: How many doses are needed? Allergy Asthma Proc 20:383-386, 1999.
37. Haymore BR, Carr WW, and Frank WT. Anaphylaxis and epinephrine prescribing patterns in a military hospital: Underutilization of the intramuscular route. Allergy Asthma Proc 26: 361-365, 2005. (Pubitemid 41565077)
38. Sampson HA, Munoz-Furlong A, Campbell RL, et al. Second symposium on the definition and management of anaphylaxis: Summary report-Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 117:391-397, 2006. (Pubitemid 43190153)
39. Boyce JA, Assa'ad A, Burks AW, et al. Guidelines for the diagnosis and management of food allergy in the United States: Summary of the NIAID-sponsored expert panel report. J Allergy Clin Immunol 126:1105-1118.
40. Waserman S, Chad Z, Francoeur MJ, et al. Management of anaphylaxis in primary care: Canadian expert consensus recommendations. Allergy 65:1082-1092, 2010.
41. Muraro A, Roberts G, Clark A, et al. The management of anaphylaxis in childhood: Position paper of the European Academy of Allergology and Clinical Immunology. Allergy 62:857-871, 2007. (Pubitemid 47037857)
42. Simons FE, Roberts JR, Gu X, and Simons KJ. Epinephrine absorption in children with a history of anaphylaxis. J Allergy Clin Immunol 101:33-37, 1998. (Pubitemid 28112878)
43. Greenberger PA, and Ditto AM. Chap. 24: Anaphylaxis. Allergy Asthma Proc 33(suppl 1):80-83, 2012.
44. Cox L, Larenas-Linnemann D, Lockey RF, and Passalacqua G. Speaking the same language: The World Allergy Organization subcutaneous immunotherapy systemic reaction grading system. J Allergy Clin Immunol 125:569-574, 74 e1-74 e7, 2010.
45. Liss GM, Murphy-Berendts K, Epstein T, and Bernstein DI. Factors associated with severe versus mild immunotherapyrelated systemic reactions: A case-referent study. J Allergy Clin Immunol 127:1298-1300, 2011.
46. Bernstein DI, Epstein T, Murphy-Berendts K, and Liss GM. Surveillance of systemic reactions to subcutaneous immunotherapy injections: Year 1 outcomes of the ACAAI and AAAAI collaborative study. Ann Allergy Asthma Immunol 104:530-535, 2010.
47. Bernstein DI, Wanner M, Borish L, and Liss GM. Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990-2001. J Allergy Clin Immunol 113:1129-1136, 2004. (Pubitemid 38857996)
48. Turkeltaub P. Deaths associated with allergenic extracts. FDA Medical Bulletin 24: May, 1994.
49. CSM Update: Desensitising vaccines. Br Med J (Clin Res Ed) 293:948, 1986.
50. Waldbott G. The prevention of anaphylactic shock. JAMA 98: 446-449, 1932.
51. Practice of Allergy, 2nd ed. Vaughan W, and Black JH (Eds). Maryland Heights, MO: CV Mosby, 1939.
52. Lamson R. So-called fatal anaphylaxis in man. JAMA 93:1775-1778, 1929.
53. Vance BM, and Strassmann G. Sudden death following injection of foreign protein. Arch Pathol 34:8490865, 1942.
54. Rands DA. Anaphylactic reaction to desensitisation for allergic rhinitis and asthma. Br Med J 281:854, 1980. (Pubitemid 10053825)
55. James LP Jr, and Austen KF. Fatal systemic anaphylaxis in man. N Engl J Med 270:597-603, 1964.
56. Pollard R. Anaphylactic reaction to desensitisation. Br Med J. 22:281, 1980.
57. Moote W, and Kim H. Allergen-specific immunotherapy. Allergy Asthma Clin Immunol 7(suppl 1):S5, 2011.
58. Alvarez-Cuesta E, Bousquet J, Canonica GW, et al Standards for practical allergen-specific immunotherapy. Allergy 61(suppl 82):1-20, 2006.
59. Bousquet J, Hejjaoui A, Dhivert H, et al. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. Systemic reactions during the rush protocol in patients suffering from asthma. J Allergy Clin Immunol 83:797-802, 1989. (Pubitemid 19127947)